These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1693780)

  • 1. Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.
    Folkers K; Feng DM; Asano N; Håkanson R; Weisenfeld-Hallin Z; Leander S
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4833-5. PubMed ID: 1693780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect.
    Håkanson R; Leander S; Asano N; Feng DM; Folkers K
    Regul Pept; 1990 Oct; 31(1):75-82. PubMed ID: 1702895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of spantide II and CP-96,345 for blockade of tachykinin-evoked contractions of smooth muscle.
    Håkanson R; Wang ZY; Folkers K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):297-301. PubMed ID: 1712587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased potency of antagonists of substance P having asparagine in position 6.
    Ljungqvist A; Chu JY; Tang PF; Bender W; Håkanson R; Leander S; Rosell S; Folkers K
    Regul Pept; 1989 Mar; 24(3):283-91. PubMed ID: 2469108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on effects of the substance P analogues [D-Pro2, D-Trp7,9]-substance P and [D-Arg1, D-Trp7,9, L-Leu11]-substance P not related to their antagonist action.
    Lembeck F; Amann R; Barthó L
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):290-3. PubMed ID: 2429194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues.
    Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
    J Med Chem; 1986 Jul; 29(7):1171-8. PubMed ID: 2433443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological assessment of spantide II analogues.
    Wang ZY; Feng DM; Wang YL; Tung SR; Wong K; Strichartz GR; Folkers K; Håkanson R
    Eur J Pharmacol; 1994 Aug; 260(2-3):121-8. PubMed ID: 7527343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of antagonists of substance P.
    Folkers K; Rosell S; Chu JY; Lu LA; Tang PF; Ljungqvist A
    Acta Chem Scand B; 1986 Apr; 40(4):295-302. PubMed ID: 2425519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological evaluation of substance P antagonists.
    Folkers K; Håkanson R; Hörig J; Xu JC; Leander S
    Br J Pharmacol; 1984 Oct; 83(2):449-56. PubMed ID: 6207886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonists.
    Håkanson R; Beding B; Ljungqvist A; Chu JY; Leander S; Trojnar J; Folkers K
    Regul Pept; 1988 Feb; 20(2):99-105. PubMed ID: 2452463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction.
    Zacharia S; Rossowski WJ; Jiang NY; Hrbas P; Ertan A; Coy DH
    Eur J Pharmacol; 1991 Oct; 203(3):353-7. PubMed ID: 1723044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects.
    Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
    J Med Chem; 1986 Jul; 29(7):1163-71. PubMed ID: 2433442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of effective antagonists of substance P.
    Folkers K; Hörig J; Rampold G; Lane P; Rosell S; Björkroth U
    Acta Chem Scand B; 1982; 36(6):389-95. PubMed ID: 6182712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.
    Bailey SJ; Jordan CC
    Br J Pharmacol; 1984 Jun; 82(2):441-51. PubMed ID: 6203595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tachykinin receptors in isolated basilar arteries of guinea-pig.
    Edvinsson L; Jansen I
    Br J Pharmacol; 1987 Mar; 90(3):553-9. PubMed ID: 2436702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of substance P from emphasis on position 11.
    Folkers K; Rosell S; Xu JC; Björkroth U; Lu YA; Liu YZ
    Acta Chem Scand B; 1983; 37(7):623-7. PubMed ID: 6197831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
    Bailey SJ; Lippe IT; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.